Back to search
FDAFDA · Food and drugs·Recall number D-0821-2020

Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704

Published February 5, 2020 · Recall initiated: February 14, 2019

Summary

FDA records drug Class II recall D-0821-2020, published February 5, 2020 and initiated February 14, 2019. Recalling firm: McGuff Compounding Pharmacy Services, Inc.; Status: Terminated; Reported quantity: N/A; Lot: Lot #18J1081, Exp 03/10/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Particulates observed in vials release for dispensing.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
McGuff Compounding Pharmacy Services, Inc.
Distributor
Prescriptions filled for patients in the following states: AK, AZ, CA, CO, DC, FL, IN, MA, MT, NC, NJ, NY, OR, SC, TX, UT, VA, WA, and WI.
Lot
Lot #18J1081, Exp 03/10/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704 recalled?

Yes. FDA published recall D-0821-2020 on February 5, 2020. Reported hazard: Presence of Particulate Matter: Particulates observed in vials release for dispensing.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone